• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤体积在胶质母细胞瘤患者预后中的重要性:计算机体积测量法与几何模型的比较

The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.

作者信息

Iliadis Georgios, Selviaridis Panagiotis, Kalogera-Fountzila Anna, Fragkoulidi Anna, Baltas Dimos, Tselis Nikolaos, Chatzisotiriou Athanasios, Misailidou Despina, Zamboglou Nikolaos, Fountzilas George

机构信息

Department of Radiation Oncology, "Papageorgiou" General Hospital, Thessaloniki, Greece.

出版信息

Strahlenther Onkol. 2009 Nov;185(11):743-50. doi: 10.1007/s00066-009-2015-7. Epub 2009 Nov 10.

DOI:10.1007/s00066-009-2015-7
PMID:19899008
Abstract

BACKGROUND AND PURPOSE

The importance of tumor volume as a prognostic factor in high-grade gliomas is highly controversial and there are numerous methods estimating this parameter. In this study, a computer-based application was used in order to assess tumor volume from hard copies and a survival analysis was conducted in order to evaluate the prognostic significance of preoperative volumetric data in patients harboring glioblastomas.

PATIENTS AND METHODS

50 patients suffering from glioblastoma were analyzed retrospectively. Tumor volume was determined by the various geometric models as well as by an own specialized software (Volumio). Age, performance status, type of excision, and tumor location were also included in the multivariate analysis.

RESULTS

The spheroid and rectangular models overestimated tumor volume, while the ellipsoid model offered the best approximation. Volume failed to attain any statistical significance in prognosis, while age and performance status confirmed their importance in progression-free and overall survival of patients.

CONCLUSION

Geometric models provide a rough approximation of tumor volume and should not be used, as accurate determination of size is of paramount importance in order to draw safe conclusions in oncology. Although the significance of volumetry was not disclosed, further studies are definitely required.

摘要

背景与目的

肿瘤体积作为高级别胶质瘤预后因素的重要性极具争议,且有多种方法可用于估算该参数。在本研究中,使用了一种基于计算机的应用程序来从硬拷贝中评估肿瘤体积,并进行了生存分析,以评估术前体积数据对胶质母细胞瘤患者的预后意义。

患者与方法

对50例胶质母细胞瘤患者进行回顾性分析。通过各种几何模型以及一款自主研发的专业软件(Volumio)来确定肿瘤体积。年龄、体能状态、切除类型和肿瘤位置也纳入了多因素分析。

结果

球体模型和矩形模型高估了肿瘤体积,而椭球体模型提供了最佳近似值。体积在预后方面未达到任何统计学意义,而年龄和体能状态证实了它们在患者无进展生存期和总生存期方面的重要性。

结论

几何模型只能对肿瘤体积进行粗略近似,不应使用,因为准确确定大小对于在肿瘤学中得出可靠结论至关重要。尽管体积测量的意义尚未明确,但肯定需要进一步研究。

相似文献

1
The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.肿瘤体积在胶质母细胞瘤患者预后中的重要性:计算机体积测量法与几何模型的比较
Strahlenther Onkol. 2009 Nov;185(11):743-50. doi: 10.1007/s00066-009-2015-7. Epub 2009 Nov 10.
2
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).一线替莫唑胺化疗后复发或进展的胶质母细胞瘤采用伊立替康联合卡莫司汀进行二线化疗:意大利神经肿瘤协作组(GICNO)的一项II期研究
J Clin Oncol. 2004 Dec 1;22(23):4779-86. doi: 10.1200/JCO.2004.06.181.
3
Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.左乙拉西坦治疗多形性胶质母细胞瘤患者同期放化疗及替莫唑胺辅助化疗的生存获益。
Cancer. 2015 Sep 1;121(17):2926-32. doi: 10.1002/cncr.29439. Epub 2015 May 14.
4
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.基线 T1 高信号和弥散受限病变与 GLARIUS 试验贝伐珠单抗治疗的胶质母细胞瘤患者的生存延长无关。
J Neurooncol. 2019 Sep;144(3):501-509. doi: 10.1007/s11060-019-03246-4. Epub 2019 Jul 19.
5
Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.洛莫司汀与替莫唑胺治疗后胶质母细胞瘤出现延迟性和持续性假性进展
J Clin Oncol. 2012 Jul 20;30(21):e180-3. doi: 10.1200/JCO.2011.40.9565. Epub 2012 Jun 11.
6
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.动态磁敏感对比增强磁共振成像测量相对脑血容量作为复发性胶质母细胞瘤总生存期的预后标志物:ACRIN 6677/RTOG 0625多中心试验结果
Neuro Oncol. 2015 Aug;17(8):1148-56. doi: 10.1093/neuonc/nou364. Epub 2015 Feb 2.
7
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.局限性边缘放疗联合替莫唑胺治疗胶质母细胞瘤的失败模式。
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):130-6. doi: 10.1016/j.ijrobp.2009.10.048. Epub 2010 Apr 14.
8
Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.术前灌注偏度和峰度是新诊断胶质母细胞瘤部分切除术后无进展生存期的潜在预测指标。
Korean J Radiol. 2016 Jan-Feb;17(1):117-26. doi: 10.3348/kjr.2016.17.1.117. Epub 2016 Jan 6.
9
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.里登肽联合替莫唑胺治疗新诊断的表皮生长因子受体VIII 表达型胶质母细胞瘤患者(ACT IV):一项随机、双盲、国际 III 期试验。
Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.
10
Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.接受多模态治疗方案的新诊断胶质母细胞瘤患者1H磁共振波谱成像(MRSI)参数早期变化与生存的相关性
Neuro Oncol. 2017 Mar 1;19(3):430-439. doi: 10.1093/neuonc/now159.

引用本文的文献

1
Fractal-Based Morphometrics of Glioblastoma.基于分形的脑胶质母细胞瘤形态计量学
Adv Neurobiol. 2024;36:545-555. doi: 10.1007/978-3-031-47606-8_28.
2
Association of MRI Volume Parameters in Predicting Patient Outcome at Time of Initial Diagnosis of Glioblastoma.胶质母细胞瘤初诊时MRI体积参数与预测患者预后的相关性
Brain Sci. 2023 Nov 10;13(11):1579. doi: 10.3390/brainsci13111579.
3
Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type.异柠檬酸脱氢酶野生型胶质母细胞瘤中细胞不成熟在坏死和微血管形成中的意义

本文引用的文献

1
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?复发性胶质母细胞瘤的低分割立体定向再照射:高剂量放疗后的一种有益治疗选择?
Strahlenther Onkol. 2009 Apr;185(4):235-40. doi: 10.1007/s00066-009-1753-x. Epub 2009 Apr 16.
2
Hypofractionated reirradiation for recurrent malignant glioma.复发恶性胶质瘤的大分割再照射
Strahlenther Onkol. 2009 Feb;185(2):113-9. doi: 10.1007/s00066-009-1969-9. Epub 2009 Feb 25.
3
A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors.
Clin Pract. 2022 Dec 13;12(6):1054-1068. doi: 10.3390/clinpract12060108.
4
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and F-FMISO PET.评估贝伐单抗治疗复发性胶质母细胞瘤失败后肿瘤缺氧和灌注情况:MRI 和 F-FMISO PET 的应用。
Sci Rep. 2021 Apr 7;11(1):7632. doi: 10.1038/s41598-021-84331-5.
5
A Nomogram Predicts Individual Prognosis in Patients With Newly Diagnosed Glioblastoma by Integrating the Extent of Resection of Non-Enhancing Tumors.一种列线图通过整合非增强肿瘤的切除范围来预测新诊断胶质母细胞瘤患者的个体预后。
Front Oncol. 2020 Dec 2;10:598965. doi: 10.3389/fonc.2020.598965. eCollection 2020.
6
Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth.工程化控制瘤周炎症以抑制脑肿瘤生长。
Adv Healthc Mater. 2019 Feb;8(4):e1801076. doi: 10.1002/adhm.201801076. Epub 2018 Dec 11.
7
Monitoring Radiation Treatment Effects in Glioblastoma: FLAIR Volume as Significant Predictor of Survival.监测胶质母细胞瘤的放射治疗效果:FLAIR体积作为生存的重要预测指标
Tomography. 2017 Sep;3(3):131-137. doi: 10.18383/j.tom.2017.00009.
8
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.VEGF-121 血浆水平作为复发性胶质母细胞瘤抗血管生成治疗反应的生物标志物。
BMC Cancer. 2018 May 10;18(1):553. doi: 10.1186/s12885-018-4442-2.
9
Volumetric assessment of tumor size changes in pediatric low-grade gliomas: feasibility and comparison with linear measurements.小儿低级别胶质瘤肿瘤大小变化的容积评估:可行性及与线性测量的比较。
Neuroradiology. 2018 Apr;60(4):427-436. doi: 10.1007/s00234-018-1979-3. Epub 2018 Jan 30.
10
Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.神经肿瘤学中的疗效评估标准、对比增强及灌注MRI用于评估胶质母细胞瘤的进展情况。
Neuroradiology. 2017 Oct;59(10):1013-1020. doi: 10.1007/s00234-017-1899-7. Epub 2017 Aug 25.
一种针对脑肿瘤的18F-FET-PET所证明的生物适应性剂量递增方法。
Strahlenther Onkol. 2008 Oct;184(10):536-42. doi: 10.1007/s00066-008-1883-6. Epub 2008 Oct 1.
4
Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.胶质母细胞瘤术后放疗联合同步替莫唑胺且不进行辅助化疗的随机研究
Strahlenther Onkol. 2008 Nov;184(11):572-9. doi: 10.1007/s00066-008-1897-0. Epub 2008 Nov 19.
5
Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.多形性胶质母细胞瘤的术后放疗:不同治疗策略及预测因素的分析与批判性评估
Strahlenther Onkol. 2007 Dec;183(12):695-702. doi: 10.1007/s00066-007-1739-5.
6
Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.利用99m锝-甲氧基异丁基异腈单光子发射计算机断层扫描(99mTc-MIBI SPECT)与磁共振成像(MRI)融合技术勾画高级别胶质瘤放疗靶区
Strahlenther Onkol. 2007 Dec;183(12):689-94. doi: 10.1007/s00066-007-1750-x.
7
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.放疗联合同步及辅助替莫唑胺治疗胶质母细胞瘤
N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
8
Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?高级别胶质瘤的放射治疗。改变分割方式能否改善治疗效果?
Strahlenther Onkol. 2004 Jul;180(7):401-7. doi: 10.1007/s00066-004-1220-7.
9
Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial.在一项随机试验中,单独放疗或联合放化疗治疗的局部晚期头颈部癌(非鼻咽癌)患者中肿瘤容积测量的预后影响
Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1018-26. doi: 10.1016/j.ijrobp.2004.01.021.
10
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.近期诊断的恶性胶质瘤手术后的生存率及预后因素:来自胶质瘤结局项目的数据。
J Neurosurg. 2003 Sep;99(3):467-73. doi: 10.3171/jns.2003.99.3.0467.